Recruiting minorities into clinical trials toward a participant-friendly system

Journal of the National Cancer Institute

Volumn 87, Issue 23, 1995, Pages 1747-1759

  Swanson, G Marie ^a   Ward, Amy J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST; HUMAN; METHODOLOGY; MINORITY GROUP; PATIENT SELECTION; PHYSICIAN ATTITUDE; POPULATION RESEARCH; REVIEW;

CLINICAL TRIALS; HUMAN; MINORITY GROUPS; PATIENT SELECTION; RESEARCH DESIGN;

EID: 0028791332     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.23.1747     Document Type: Article

References (107)

1. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and armotated bibliography. Control Clin Trials 1987;8(4 Suppl);6S-30S.
2. Ashery RS, McAuliffe WE. Implementation issues and techniques in randomized tnals of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse 1992;18:305-29.
3. Bradford RH. Participant recruitment to the Lipid Research Clinics Coronary Primary Prevention Trial. Control Clin Trials 1987;8(4 Suppl):31S-40S.
4. Williams GW, Snedecor SM, DeMets DL. Recruitment experience in the Nocturnal Oxygen Therapy Trial. Control Clin Trials 1987;8(4 Suppl):121S-30S.
5. Farrar WB. Clinical trials: access and reimbursement. Cancer 1991;67(6 Suppl):1779S-82S.
6. Gotay CC. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med 1991;33:569-77.
7. Tangrea JA, Adrianza ME, Hcisel WE. Patients’ perceptions on participation in a cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev 1992;1:325-30.
8. Foley JF, Moertel CG. Improving accrual into cancer clinical trials. J Cancer Educ 1991;6:165-73.
9. Wagner EH, Schoenback VJ, Orleans CT, Grothaus LC, Saunders KW, Curry S, et al. Participation in a smoking cessation program: a population-based perspective. Am J Prev Med 1990;6:258-66.
10. Neaton JD, Grimm RH Jr, Cutler JA. Recruitment of participants for the multiple risk factor intervention trial (MRFIT). Control Clin Trials 1987;8(4Suppl):41S-53S.
11. Agras WS, Marshall G. Recruitment for the Coronary Primary Prevention Trial. Clin Pharmacol Ther 1979;25(Pt 2):688-90.
12. Taylor KM, Margolese RG, Soskolne CL. Physicians’ reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 1984;310:1363-7.
13. Ganz PA. Clinical trials. Concerns of the patient and the public. Cancer 1990:65(10 Suppl):2394S-9S.
14. Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patients’ pomt of view. Control Clin Trials 1985;6:156-67.
15. Taylor KM. Integrating conflicting professional roles: physician panicipa-tion in randomized clinical trials. Soc Sci Med 1992;15:217-24.
16. Svensson CK. Representation of American blacks in climeal trials of new drugs. JAMA 1989;261:263-5.
17. Connett JE, Bjomson-Benson WM, Daniels K. Recruitment of participants in the Lung Health Study, O: assessment of recruitment strategies. Control Clin Trials 1993; 14(2 Suppl):38S-51S.
18. Durkin DA, Kjelsberg MO, Buist AS, Connert JE, Owens GR. Recruitment of participants in the Lung Health Study, 1: description of methods. Control Clin Trials 1993; 14(2 Suppl):20S-37S.
19. Bjomson-Benson WM, Stibolt TB, Manské KA, Zavela KJ, Youtsey DJ, Buist AS. Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials 1993; 14(2 Suppl):52S-67S.
20. Shea S, Bigger JT Jr, Campion J, Fleiss JL, Rolnitzky LM, Schron E, et al. Eruollment in clinical trials: institutional factors affecting enrollment in the Cardiac Arrhythmia Suppression Trial (CAST). Control Clm Trials 1992;13:466-86.
21. Borhan NO, Tonascia J, Schlundt DC, et al. Recmitment in the hypertension prevention trial. Controlled Clin Trials 1989;10(3 Suppl):30S-39S.
22. Carew BD, Ahn SA, Boichot HD, Dierenfeldt BJ, Dolan NA, Edens TR, et al. Recruitment strategies in the studies of left venuicular dysfunction (SOLVD): strategies for screening and enrollment in two concurrent but separate trials. The SOLVD Investigators. Control Clin Trials 1992; 13:325-38.
23. Wadland WC, Hughes JR, Seeker-Walker RH, Bronson DL, Fenwick J. Recruitment in a primary care trial on smoking cessation. Fam Med 1990;22:201-4.
24. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Federal Register 1994;59:14508-13.
25. Hunter CP, Frehck RW, Feldman AR, Bavier AR, Dunlap WH, Ford L, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician’s Patienl Log Cancer Trea Rep 1987;71:559-65.
26. Ford CE, Langford HG, Palmer MJ. Recruitment in the hypertension detection and follow-up program. Control Clin Trials 1987;8(4 Suppl): 54S-67S.
27. Buchwald H, Matts JP, Hansen BJ, Long JM, Fitch LL. Program on Surgical Control of the Hyperlipidemias (POSCH): recruitment experience. Control Clm Trials 1987;8(4 Suppl):94S-104S.
28. Antman KH. Summary of Institute of Medicine study of resources for clinical investigation. J Natl Cancer Inst 1989;81:402-3.
29. iber F, Riley WA, Murray PJ. Recruitment. In: Iber F, Riley WA, Murray PJ, editors. Conducting clinical trials. New York: Plenum Press, 1987: 107-23.
30. Freeman HP. The impact of clinical trial protocols on patient care systems in a large city hospital. Access for the socially disadvantaged. Cancer 1993;72(9Suppl):2834-8.
31. Murdaugh C. Recruitment issues in research with special populations. J Cardiovasc Nurs 1990;4:51-5.
32. Wermeling DP, Selwitz AS. Current issues surrounding women and minorities in drug trials [see comment citation in Medline]. Arm Phar-macother 1993;27:904-11.
33. Nickens HW. Health promotion and disease prevention among minorities. Health Aff 1990;9:133-43.
34. Mohiuddin SM, Hilleman DE. Gender and racial bias in clinical pharmacology trials [see comment citation in Medlme]. Ann Pharmacother 1993;27:972-3.
35. Smith MD. Zidovudine. Does it work for everyone? [see comment citation in Medline]. JAMA 1991;266:2750-1.
36. Bennett JC. Inclusion of women in clinical trials-policies for population subgroups [see comment citation in Medline]. N Engl J Med 1993; 329:288-92.
37. Elks ML. The right to participate in research studies. J Lab Clin Med 1993;122:130-6.
38. Novick A. Noncompliance in clinical trials: I. Subjects. AIDS Pub Pol J 1989;4:125-30.
39. Nelson C. Cancer screening, clinical trials for African Americans still problematic [news]. J Natl Cancer Inst 1994;86:1753-4.
40. Crews DE, Bindon JR. Ethnicity as a taxonomic tool in biomedical and biosocial research. Ethn Dis 1991;1:42-9.
41. Merkalz RB, Temple R, Subel S, Feiden K, Kessler DA. Women in clinical trials of new drugs. A change in Food and Drag Administration policy. The Working Group on Women in Clinical Trials [see comment citation in Medline]. N Engl J Med 1993;329:292-6.
42. Short PF, Cornelius U, Goldstone DE. Health insurance of minorities in the United States [see comment citation in Medline]. J Health Care Poor Underserved 1990;1:9-24.
43. Blendon RJ, Scheck AC, Donelan K, Hill CA, Smith M, Beatrice D, et al. How white and African Americans view their health and social problems. Different experiences, different expectations. JAMA 1995;273:341-7.
44. Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, Wamecke R, et al. Assuring access to state-of-the-art care for U.S. minority populations: the fust 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst 1993;85:1945-50.
45. McCabe MS, Varricchio CG, Padberg RM. Efforts to recruit the economically disadvantaged to national clinical trials. Semin Oncol Nurs 1994; 10:123-9.
46. Millon-Underwood S, Sanders E, Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African Americans. CaiKer Nurs 1993; 16:25-33.
47. Jimenez MA, Jimenez DR. Latinos and HIV disease. Issues, practice and policy implications. Soc Work Health Care 1992; 17:41-51.
48. Heilman S, Heilman DS. Of mice but not men. N Engl J Med 1991;324:1585-9.
49. Spodick DH. Randomized controlled clinical trials: the behavioral case. JAMA 1982;247:2258-60.
50. Johansen MA, Mayer DK, Hoover HC Jr. Obstacles to implementing cancer clinical trials. Semin Oncol Nurs 1991;7:260-7.
51. Engelking C. Facilitating clinical trials. The expanding role of the nurse. Cancer 1991;67:1793-7.
52. Hunninghake DB. Summary conclusions. Controlled Clin Trials 1987; 8:1S-5S.
53. O’Fallon WM, Rings L, Gonzalez R, Burnett J, Golda C, Hayes G, et al. Natural history study of congenital heart defects. Control Clin Trials 1987;8(4Suppl):115S-l20S.
54. Knanerud GL, Forman SA. Patient recruitment experience in the Thrombolysis in Myocardial Infarction Trial. Control Clin Trials 1987;8(4 Suppl):86S-93S.
55. Goldstein S, Byington R. The Beta Blocker Heart Attack Trial: recmitment experience. Control Clin Trials 1987;8 (4Suppl):79S-85S.
56. Gaston M, Smith J, Gallagher D, Floumoy-Gill Z, West S, Bellevue R, et al. Recmitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control Clin Trials 1987;8(4 Suppl): 131S-140S.
57. Schoenberger JA. Recmitment experience m the Aspirin Myocardial Infarction Study. Control Clm Trials 1987;8(4 Suppl):74S-78S.
58. Kelly RB, McMahon SH, Hazey JA. Does practice location or academic connection affect recmitment of patients as research subjects? Fam Pract Res J 1992;12:177-84.
59. Hughes GH, Cutter G, Donahue R, Friedman GD, Hulley S, Hunkeler E, el al. Recmitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) Study. Control Clin Trials 1987;8(4 Suppl): 68S-73S.
60. Langley GR, Sutherland HJ, Wong S, Minkin S, Llewellyn-Thomas HA, Till JE. Why are (or are not) patients given the option to enter clinical trials? Conuol Clin Trials 1987;8:49-59.
61. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59-65.
62. Fortmann SP, Killen JD. Who shall quit? Comparison of volunteer and population-based recmitment m two minimal-contact smoking cessation studies. Am J Epidemiol 1994;140:39-51.
63. Williams RR, Hunt SC. Recmitment of members of high-risk Utah pedigrees. Control Qin Trials 1987;8(4 Suppl): 105S-114S.
64. Martinez NC. Diabetes and minority populations. Focus on Mexican Americans. Nurs Clin North Am 1993;28:87-95.
65. Walker R, Lucas W, Crespo R. The West Virginia Rural Cancer Prevention Project. Cancer FYact 1994;2:421-6.
66. Hutchinson J. AIDS and racism in America. J Nad Med Assoc 1992;84:119-24.
67. Welty TK. Cancer and cancer prevention and control programs in the Aberdeen area Indian health service. Am Indian Culture Res J 1992;16:117-38.
68. el-Sadr W, Capps L. The challenge of minority recmitment in clinical trials for AIDS. JAMA 1992;267:954-7.
69. Hazuda HP, Comeaux PJ, Stem MP, Haffner SM, Eifler CW, Rosenthal M. A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study. Am J Epidemiol 1986;123:96-112.
70. Lewontin RC. The apportiorunent of human diversity. In: Dobzhansky Th, et al, editors. Evolutionary biology, Vol 6. New York: Plenum, 1972: 381-98.
71. Hu DJ, Keller R, Fleming D. Communicating AIDS information to Hispanics: the importaiKe of language and media preference. Am J Prev Med 1989;5:196-200.
72. Freeman HP. Cancer in the socioeconomically disadvantaged [see comment citation in Medline]. CA Cancer J Qin 1989;39:266-89.
73. Groce NE, Zola IK. Multiculturalism, chronic illness, and disability. Pediatrics 1993;91(5 Pt2):1048-55.
74. Thomas CR Jr, Pinto HA, Roach M 3rd, Vaughn CB. Participation in clinical trials: is it state-of-the-art treatment for African Americans and other people of color? J Natl Med Assoc 1994;86:177-82.
75. Snow L. Walkin’ over medicine Boulder (CXD): Westview Press, 1993:264-74.
76. Jones JH. Bad blood: the Tuskegee Syphilis Experiment. New York: The Free Press, 1981.
77. Wray LA. Health policy and ethnic diversity in older Americans. Dissonance or harmony? West JMed 1992;157:357-61.
78. Lacey L. Cancer prevention and early detection strategies for reaching un-derservcd urban, low-income black women. Barriers and objectives. Cancer 1993;72(3 Suppl): 1078-83.
79. Reis J, Sherman S, Macon J. Teaching inner-city mothers about family planning and prenatal and pediatric services. J Pediatr Health Care 1989;3:251-6.
80. Hunter CP. Cancer control and the community oncology programs: minority participation in the National Cancer Institute clinical trials network. In: Jones LA, editor. Minorities and cancer. New York: SpringerVerlag, 1989:95-101.
81. DuRant RH, Ashworth CS, Newman CL, McGUl L, Raban C, Baranowski T. AIDS/HIV knowledge level and perceived chance of having HTV among rural adolescents. J Adolesc Health 1992;13:499-505.
82. Kmdig DA, Yan G. Physician supply in rural areas with large minority populations. Health Aff 1993;12:177-84.
83. Haynes MA, Bernard U. Drew/Meharry/Morehouse Consortium Cancer Center an approach to targeted research in minority institutions. J Natl Med Assoc 1992;84:505-11.
84. Blum A. Role of the health professional in ending the tobacco pandemic: clmic, classroom, and commimity. Monogr Natl Cancer Inst 1992;12:37-43.
85. Thomas SB, Quinn SC, Billingsley A, Caldwell C. The characteristics of northern black churches with community health outreach programs. Am J Public Health 1994;84:575-9.
86. Ballard EL, Nash F, Raiford K, Harrell LE. Recruitment of black elderly for clinical research smdies of dementia: the CERAD experience. Gerontologist 1993;53:561-5.
87. Quirk ME, Godkin MA, Schwenzfeier E. Evaluation of two AfDS prevention interventions for inner-city adolescent and young adult women. Am J Prev Med 1993;9:21-6.
88. Hirsch SH, Mayer-Oakes A, Schweitzer S, Atchison KA, Lubben JE, DeJong F. Enrolling community physicians and their patients in a study of prevention in the elderly. Public Health Rep 1992;107:142-9.
89. Mack E, McGrath T, Pendleton D, Zieber NA. Reaching poor populations with cancer prevention and early detection programs. Cancer Pract 1993;1:35-9.
90. Braithwaite RL, Murphy F, Lythcott N, Blumenthal DS. Community organization and development for health promotion within an urbaa black community: aconcepmal model. Health Educ 1989;20:56-60.
91. Renneker M, Lim N, Wheatley B, Collins S, Pirkle R, Beers L, et al. An mner-city cancer prevention clinic in West Oakland, California. Cancer Pract 1994;2:427-37.
92. Longoria JM, Turner NH, Phillips BU Jr. Community leaders help increase response rates in AIDS survey. Am J Public Health 1991;81:654-5.
93. Yeans DE, Crow T, Foils E. Service use among low-income minority elderly: strategies for overcoming barriers. Gerontologist 1992;32:24-32.
94. Millon-Undcrwood S, Sanders E. Factors contributing to health promotion behaviors among African-American men. Oncol Nurs Fomm 1990;15:707-12.
95. Chlebowski RT, Butler J, Nelson A, Lillington L. Breast cancer chemo-prevention. Tamoxifen: Current issues and future prospective. Cancer 1993;72(3 Suppl): 1032-7.
96. Botvin GJ, Diusenbury L, Baker E, James-Ortiz S, Botvin EM, Ketner J. Smoking prevention among urban minority youth: assessing effects on outcome and mediating variables. Health Psychol 1992;11:290-9.
97. Satcher D. The role of minority academic health centers. In: Jones LA, editor. Minorities and cancer. New York: Springer-Verlag, 1989:321-5.
98. Jenkins CN, MePhee SJ, Bird JA, Bonilla NT. Cancer risks and prevention practices among Viemamese refugees [published erratum appears in West JMed 1990;153:331]. West J Med 1990;153:34-9.
99. Reiskin H, Lindenberg CS. Involving the target population and their providers in evaluation of substance abuse videos. Nursing Connections 1992;5;47-54.
100. Safer LA, Harding CG. Under pressure program: using live theatre to investigate adolescents’ attitudes and behavior related to drug and alcohol abuse education and prevention. Adolescence 1993;28:135-48.
101. Melton GB, Levine RJ, Koocher GP, Rosenthal R, Thompson WC. Community consultation in socially sensitive research. Lessons from clinical trials of treatments for AIDS. Am Psychol 1988;43:573-81.
102. Kauffman KS. The insider/outsider dilemma: field experience of a white researcher getting in a poor black community. Nurs Res 1994;43:179-83.
103. Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist 1990;30:100-6.
104. Brown DR, Gary LE. Religious involvement and health status among African-American males. J Natl Med Assoc 1994;86:825-31.
105. Morales ES, Fullilove MT. ‘Many are called…’: participanon by minority leaders in an AIDS mtervention in San Francisco. Ethn Ehs 1992;2:389-401.
106. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerieider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994;74(7Suppl):2208-14.
107. Foley G. Serving the underserved [see comment citations in Medline]. Cancer Pract 1993;2:247.